These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11061983)

  • 1. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
    Mohammed SP; Taylor CV; Weyman-Jones CB; Mather ME; Vendy K; Dougall IG; Young A
    Pulm Pharmacol Ther; 2000; 13(6):287-92. PubMed ID: 11061983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
    Whelan CJ; Johnson M; Vardey CJ
    Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.
    Anderson P; Lötvall J; Lindén A
    Lung; 1996; 174(3):159-70. PubMed ID: 8830192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol.
    Nials AT; Ball DI; Butchers PR; Coleman RA; Humbles AA; Johnson M; Vardey CJ
    Eur J Pharmacol; 1994 Jan; 251(2-3):127-35. PubMed ID: 8149969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
    Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
    Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
    Aparici M; Gómez-Angelats M; Vilella D; Otal R; Carcasona C; Viñals M; Ramos I; Gavaldà A; De Alba J; Gras J; Cortijo J; Morcillo E; Puig C; Ryder H; Beleta J; Miralpeix M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):497-509. PubMed ID: 22588259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices.
    Sturton RG; Trifilieff A; Nicholson AG; Barnes PJ
    J Pharmacol Exp Ther; 2008 Jan; 324(1):270-5. PubMed ID: 17916760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
    Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
    J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus.
    Naline E; Zhang Y; Qian Y; Mairon N; Anderson GP; Grandordy B; Advenier C
    Eur Respir J; 1994 May; 7(5):914-20. PubMed ID: 7914176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and binding characteristics of long-acting beta 2-agonists in lung and heart.
    Roux FJ; Grandordy B; Douglas JS
    Am J Respir Crit Care Med; 1996 May; 153(5):1489-95. PubMed ID: 8630591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
    Anderson GP
    Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
    Lindén A; Rabe KF; Löfdahl CG
    Lung; 1996; 174(1):1-22. PubMed ID: 8746998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor.
    Patel S; Summerhill S; Stanley M; Perros-Huguet C; Trevethick MA
    Pulm Pharmacol Ther; 2011 Apr; 24(2):247-55. PubMed ID: 21134482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
    Ryall JG; Sillence MN; Lynch GS
    Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the anti-bronchoconstrictor activities of inhaled formoterol, its (R,R)- and (S,S)-enantiomers and salmeterol in the rhesus monkey.
    Fozard JR; Buescher H
    Pulm Pharmacol Ther; 2001; 14(4):289-95. PubMed ID: 11440557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inquiry into the mechanism of long-acting bronchodilators].
    Bao Y; Lemoine H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):191-6. PubMed ID: 11367704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action.
    Nicholls DJ; Jordan S; Cadogan E; Lawson M; Austin RP; Paine SW; Gardiner P; Bonnert R; Connolly S; Young A
    Pulm Pharmacol Ther; 2012 Aug; 25(4):293-302. PubMed ID: 22659538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
    Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
    Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of long-acting beta-receptor agonists.
    Tattersfield AE
    Life Sci; 1993; 52(26):2161-9. PubMed ID: 8099697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.